• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血小板与淋巴细胞比值可预测维持性血液透析患者的全因死亡率和心血管死亡率。

A high platelet-to-lymphocyte ratio predicts all-cause mortality and cardiovascular mortality in maintenance hemodialysis patients.

机构信息

Department of Blood Purification, General Hospital of Northern Theatre Command, Shenyang, Liaoning, China.

出版信息

Ren Fail. 2023;45(2):2258228. doi: 10.1080/0886022X.2023.2258228. Epub 2023 Sep 19.

DOI:10.1080/0886022X.2023.2258228
PMID:37724554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10512768/
Abstract

PURPOSE

The aim of this study was to further assess whether the platelet-to-lymphocyte ratio (PLR) is independently associated with all-cause mortality and cardiovascular mortality in maintenance hemodialysis (MHD) patients.

METHODS

From January 1, 2014, to December 31, 2014, patients undergoing regular hemodialysis in the Blood Purification Center of the General Hospital of Northern Theatre Command were retrospectively selected. A total of 303 MHD patients were enrolled in accordance with the inclusion and exclusion criteria. For each patient, the endpoint of follow-up was either death or December 31, 2021. The primary endpoints were all-cause and cardiovascular death. A receiver operating characteristic (ROC) curve was drawn to detect the predictive ability of PLR, and the optimal critical value of PLR was determined to be 107.57. Kaplan-Meier curves and Cox proportional analysis were used to assess the prognostic value of PLR. We used the same method to evaluate the correlation between the neutrophil-to-lymphocyte ratio (NLR) and the prognosis of MHD patients.

RESULTS

At the end of follow-up, 128 MHD patients had progressed to all-cause death, and 73 MHD patients had progressed to cardiovascular death. In multivariate Cox regression, both the high PLR group and the high NLR group were independently associated with all-cause mortality (HR 2.608, 95% CI 1.579-4.306,  < .001 vs. HR 1.634, 95% CI 1.023-2.610,  = .04). Only high PLR expression was associated with cardiovascular mortality (HR 3.379, 95% CI 1.646-6.936,  = .001).

CONCLUSIONS

High PLR levels can independently predict all-cause and cardiovascular mortality in MHD patients.

摘要

目的

本研究旨在进一步评估血小板与淋巴细胞比值(PLR)是否与维持性血液透析(MHD)患者的全因死亡率和心血管死亡率独立相关。

方法

回顾性选取 2014 年 1 月 1 日至 2014 年 12 月 31 日在北部战区总医院血液净化中心接受常规血液透析的患者。根据纳入和排除标准,共纳入 303 例 MHD 患者。每位患者的随访终点为死亡或 2021 年 12 月 31 日。主要终点为全因和心血管死亡。绘制受试者工作特征(ROC)曲线以检测 PLR 的预测能力,并确定 PLR 的最佳临界值为 107.57。使用 Kaplan-Meier 曲线和 Cox 比例分析评估 PLR 的预后价值。我们使用相同的方法评估中性粒细胞与淋巴细胞比值(NLR)与 MHD 患者预后的相关性。

结果

随访结束时,128 例 MHD 患者发生全因死亡,73 例 MHD 患者发生心血管死亡。多变量 Cox 回归分析显示,高 PLR 组和高 NLR 组均与全因死亡率独立相关(HR 2.608,95%CI 1.579-4.306, < .001 比 HR 1.634,95%CI 1.023-2.610, = .04)。只有高 PLR 表达与心血管死亡率相关(HR 3.379,95%CI 1.646-6.936, = .001)。

结论

高 PLR 水平可独立预测 MHD 患者的全因和心血管死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef58/10512768/b0c97467d09a/IRNF_A_2258228_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef58/10512768/3b17aff8c4c7/IRNF_A_2258228_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef58/10512768/b0c97467d09a/IRNF_A_2258228_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef58/10512768/3b17aff8c4c7/IRNF_A_2258228_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef58/10512768/b0c97467d09a/IRNF_A_2258228_F0002_C.jpg

相似文献

1
A high platelet-to-lymphocyte ratio predicts all-cause mortality and cardiovascular mortality in maintenance hemodialysis patients.高血小板与淋巴细胞比值可预测维持性血液透析患者的全因死亡率和心血管死亡率。
Ren Fail. 2023;45(2):2258228. doi: 10.1080/0886022X.2023.2258228. Epub 2023 Sep 19.
2
Study on the Clinical Implications of NLR and PLR for Diagnosing Frailty in Maintenance Hemodialysis Patients and Their Correlations with Patient Prognosis.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对维持性血液透析患者衰弱诊断的临床意义及其与患者预后的相关性研究。
J Healthc Eng. 2022 Jan 12;2022:1267200. doi: 10.1155/2022/1267200. eCollection 2022.
3
Platelet-to-lymphocyte ratio predicts mortality better than neutrophil-to-lymphocyte ratio in hemodialysis patients.在血液透析患者中,血小板与淋巴细胞比值比中性粒细胞与淋巴细胞比值更能预测死亡率。
Int Urol Nephrol. 2016 Aug;48(8):1343-1348. doi: 10.1007/s11255-016-1301-4. Epub 2016 Apr 27.
4
[Association of platelet/lymphocyte ratio and neutrophil/lymphocyte ratio with protein-energy wasting in maintenance hemodialysis patients].[维持性血液透析患者血小板/淋巴细胞比值及中性粒细胞/淋巴细胞比值与蛋白质能量消耗的关系]
Zhonghua Yi Xue Za Zhi. 2019 Feb 26;99(8):587-592. doi: 10.3760/cma.j.issn.0376-2491.2019.08.005.
5
High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Associated with Poor Survival in Patients with Hemodialysis.高中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值与血液透析患者的不良生存相关。
Biomed Res Int. 2021 May 19;2021:9958081. doi: 10.1155/2021/9958081. eCollection 2021.
6
Prognostic value of the combination of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio on mortality in patients on maintenance hemodialysis.中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值及血小板与淋巴细胞比值联合对维持性血液透析患者死亡率的预后价值。
BMC Nephrol. 2022 Dec 8;23(1):393. doi: 10.1186/s12882-022-03020-1.
7
Combined evaluation of Geriatric nutritional risk index and Neutrophil to lymphocyte ratio for predicting all-cause and cardiovascular mortality in hemodialysis patients.联合评估老年营养风险指数和中性粒细胞与淋巴细胞比值预测血液透析患者全因和心血管死亡率。
PLoS One. 2023 Jun 29;18(6):e0287696. doi: 10.1371/journal.pone.0287696. eCollection 2023.
8
[Relationship between platelet/lymphocyte ratio and cognitive impairment in diabetic patients treated with maintenance hemodialysis].维持性血液透析治疗的糖尿病患者血小板/淋巴细胞比值与认知障碍的关系
Zhonghua Yi Xue Za Zhi. 2021 Mar 16;101(10):722-726. doi: 10.3760/cma.j.cn112137-20201202-03244.
9
Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.系统免疫炎症指数、中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值可预测纳武利尤单抗治疗转移性非小细胞肺癌患者的临床结局。
J Clin Lab Anal. 2019 Oct;33(8):e22964. doi: 10.1002/jcla.22964. Epub 2019 Jul 8.
10
[Predictive value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for 28-day death in patients treated with extracorporeal membrane oxygenation].[体外膜肺氧合治疗患者中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对28天死亡率的预测价值]
Zhonghua Nei Ke Za Zhi. 2023 Mar 1;62(3):310-315. doi: 10.3760/cma.j.cn112138-20220421-00294.

引用本文的文献

1
Association of neutrophil-lymphocyte ratio with cardiovascular and all-cause mortality in patients receiving chronic hemodialysis: Systematic review and meta-analysis.接受慢性血液透析患者中性粒细胞与淋巴细胞比值与心血管及全因死亡率的关联:系统评价与荟萃分析
World J Methodol. 2025 Dec 20;15(4):107468. doi: 10.5662/wjm.v15.i4.107468.
2
Correlation between CBC-derived inflammatory indicators and all-cause mortality with rheumatoid arthritis: a population-based study.全血细胞计数衍生的炎症指标与类风湿关节炎全因死亡率之间的相关性:一项基于人群的研究。
Front Med (Lausanne). 2025 Jun 10;12:1538710. doi: 10.3389/fmed.2025.1538710. eCollection 2025.
3

本文引用的文献

1
The Predictive Value of NLR, MLR, and PLR in the Outcome of End-Stage Kidney Disease Patients.中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值及血小板与淋巴细胞比值对终末期肾病患者预后的预测价值
Biomedicines. 2022 May 29;10(6):1272. doi: 10.3390/biomedicines10061272.
2
The association between platelet-lymphocyte ratio and the risk of all-cause mortality in chronic kidney disease: a systematic review and meta-analysis.血小板-淋巴细胞比值与慢性肾脏病全因死亡率风险的关系:系统评价和荟萃分析。
Int Urol Nephrol. 2022 Nov;54(11):2959-2967. doi: 10.1007/s11255-022-03234-0. Epub 2022 May 17.
3
High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Associated with Poor Survival in Patients with Hemodialysis.
Association between neutrophil percentage-to-albumin ratio and mortality in Hemodialysis patients: insights from a prospective cohort study.
血液透析患者中性粒细胞百分比与白蛋白比值和死亡率之间的关联:一项前瞻性队列研究的见解
BMC Nephrol. 2025 Mar 4;26(1):112. doi: 10.1186/s12882-025-04027-0.
4
A novel nomogram for predicting mortality risk in young and middle-aged patients undergoing maintenance hemodialysis: a retrospective study.一种用于预测接受维持性血液透析的中青年患者死亡风险的新型列线图:一项回顾性研究。
Front Med (Lausanne). 2025 Jan 7;11:1508485. doi: 10.3389/fmed.2024.1508485. eCollection 2024.
5
Construction of a C-reactive protein-albumin-lymphocyte index-based prediction model for all-cause mortality in patients on maintenance hemodialysis.构建基于C反应蛋白-白蛋白-淋巴细胞指数的维持性血液透析患者全因死亡率预测模型。
Ren Fail. 2025 Dec;47(1):2444396. doi: 10.1080/0886022X.2024.2444396. Epub 2025 Jan 14.
6
Development and validation of a model for predicting the risk of cardiovascular events in maintenance hemodialysis patients.开发和验证一种用于预测维持性血液透析患者心血管事件风险的模型。
Sci Rep. 2024 Mar 21;14(1):6760. doi: 10.1038/s41598-024-55161-y.
高中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值与血液透析患者的不良生存相关。
Biomed Res Int. 2021 May 19;2021:9958081. doi: 10.1155/2021/9958081. eCollection 2021.
4
The Relationship between Serum Ferritin Levels and 5-Year All-Cause Mortality in Hemodialysis Patients.血清铁蛋白水平与血液透析患者 5 年全因死亡率的关系。
Blood Purif. 2022;51(1):55-61. doi: 10.1159/000515639. Epub 2021 Apr 7.
5
Diagnostic Sensitivity of NLR and PLR in Early Diagnosis of Gastric Cancer.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值在胃癌早期诊断中的诊断灵敏度。
J Immunol Res. 2020 Mar 7;2020:9146042. doi: 10.1155/2020/9146042. eCollection 2020.
6
Platelet-to-lymphocyte ratio is associated with cardiovascular disease in continuous ambulatory peritoneal dialysis patients.血小板与淋巴细胞比值与持续性不卧床腹膜透析患者心血管疾病相关。
Int Immunopharmacol. 2020 Jan;78:106063. doi: 10.1016/j.intimp.2019.106063. Epub 2019 Dec 10.
7
Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by Molecules.心血管疾病中的血小板功能:分子的激活与分子激活。
Cardiovasc Toxicol. 2020 Feb;20(1):1-10. doi: 10.1007/s12012-019-09555-4.
8
The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases.血小板与淋巴细胞比值作为风湿性疾病的炎症标志物。
Ann Lab Med. 2019 Jul;39(4):345-357. doi: 10.3343/alm.2019.39.4.345.
9
Cardiovascular disease in dialysis patients.透析患者的心血管疾病。
Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii28-iii34. doi: 10.1093/ndt/gfy174.
10
Chronic inflammation in end-stage renal disease and dialysis.终末期肾病和透析中的慢性炎症。
Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii35-iii40. doi: 10.1093/ndt/gfy175.